Tamoxifen is a selective estrogen receptor modulator (SERM) that is used for adjuvant hormonal therapy in estrogen receptor (ER)-positive breast cancer in both premenopausal and postmenopausal women [79]. Here, ESR1 is linked to breast carcinoma.